FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
  1. Home
  2. JMFINANCIL Forum

JMFINANCIL

93.15 +0.15 (0.16%)
Updated 12:52 28/09 IST
100% Bullish
0% Bearish
3 Users have submitted 3 trade ideas of Rs. 147,026.5 for JMFINANCIL
Disclaimer

Brokerage Reports

No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
Consensus Potential
0.00%
See JMFINANCIL Share Price Targets >>

JMFINANCIL Share Price Discussion


Type
Buy
Instrument
JMFINANCIL
Entry Price
₹90.8
Price@Trade
₹90.85
Target Price
₹92.5
Stop Price
₹86
Valid Till
Sep 20, 2021 3:20 AM
Margin
₹45,400 approx for 500 Qty
Status
Waiting for entry
Like
Reply
swap_vert
Trade
N
Reputation: 17,842 • Sep 17 11:26 AM
JM Financial to raise Rs 500 crore via public bond sales
Local rating companies – ICRA and CRISIL rated those papers with AA (Stable outlook). Bonds will offer up to 8.30 percent. Maturities are spread across 39 months to 100 months.
The Economic Times
Like
Reply
N
Reputation: 17,842 • Sep 16 5:26 AM
JM Financial's subsidiary to raise up to Rs 500 crore
"JM Financial Products has filed the shelf prospectus and tranche I prospectus with the Registrar of Companies, Mumbai and the Sebi," JM Financial said in a regulatory filing.
The Economic Times
Like
Reply
N
Reputation: 17,842 • Sep 16 3:31 AM
Buy JM Financial, target price Rs 96: HDFC Securities
JM Financial Ltd. key Products/Revenue Segments include Fees & Commission Income, Income From Financial Services and Interest for the year ending 31-Mar-2021.
The Economic Times
Like
Reply

Type
Buy
Instrument
JMFINANCIL
Entry Price
₹93.1
Price@Trade
₹93.1
Target Price
₹200
Stop Price
₹50
Valid Till
Sep 15, 2022 3:20 AM
Margin
₹68,894 approx for 740 Qty
Status
Active
Like
Reply
swap_vert
Trade

Type
Buy
Instrument
JMFINANCIL
Entry Price
₹92.75
Price@Trade
₹92.75
Target Price
₹109
Stop Price
₹89
Valid Till
Sep 15, 2022 3:20 AM
Margin
₹1,947.75 approx for 21 Qty
Status
Active
Like
Reply
swap_vert
Trade
N
Reputation: 152 • Sep 15 3:47 AM
Like
Reply
N
Reputation: 17,842 • Sep 14 8:06 AM
After a 30% rally, can HUL rerate further? Here is what analysts say
Given the scope of premiumisation in product categories, cost-saving initiatives, focus on acquiring digital capabilities and the management commentary on double-digit growth in earnings, most brokerages said the stock could rise up to 20 per cent over the next 12 months.
The Economic Times
Like
Reply
N
Reputation: 17,842 • Sep 13 4:56 AM
What's next for Nifty? 2009, 2003 market cycles offer clues
History suggests Indias 125 per cent re-rating-driven rally from March 2020 lows was similar to early market cycles of 2003 (Nifty up 91 per cent) and 2009 (Nifty up 138 per cent) where the market delivered outsized returns from depressed levels, thanks to low cost of capital.
The Economic Times
Like
Reply
N
Reputation: 152 • Sep 9 8:18 AM
Like
Reply

Type
Buy
Instrument
JMFINANCIL
Entry Price
₹90.05
Price@Trade
₹90.05
Target Price
₹91
Stop Price
₹87
Valid Till
Sep 8, 2021 3:20 AM
Margin
₹90,050 approx for 1000 Qty
Status
Validity Over
Exit Price
₹89.6
Net P&L
-₹450 (-0.5%)
Like
Reply (1)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Sep 8 8:51 AM

Update
Validity Over
Exit Price
₹89.6
Net P&L
-₹450 (-0.5%)
D
Reputation: 0 • Sep 2 6:34 AM

Type
Buy
Instrument
JMFINANCIL
Entry Price
₹92
Price@Trade
₹92
Target Price
₹92.5
Stop Price
₹90
Valid Till
Sep 2, 2021 3:20 AM
Margin
₹9,200 approx for 100 Qty
Status
Exited
Exit Price
₹92
Net P&L
₹0 (0%)
Like
Reply (1)
swap_vert
Trade
See all replies
Dune @dune
Sep 2 7:43 AM

Update
Exited
Exit Price
₹92
Net P&L
₹0 (0%)

Type
Buy
Instrument
JMFINANCIL
Entry Price
₹92.7
Price@Trade
₹92.7
Target Price
₹120
Stop Price
₹90
Valid Till
Sep 2, 2021 3:20 AM
Margin
₹9,270 approx for 100 Qty
Status
Exited
Exit Price
₹91.9
Net P&L
-₹80 (-0.86%)
Like
Reply (1)
swap_vert
Trade
See all replies

Update
Exited
Exit Price
₹91.9
Net P&L
-₹80 (-0.86%)
N
Reputation: 17,842 • Aug 31 6:56 AM
Will Burger King India's entry into 4th most populated country make it a tastier bet?
Analysts said there were growth prospects in Indonesia and the acquisition was attractive value-wise. The deal could increase the fair value of Burger King India by Rs 25 apiece, they said. But for now, they have kept the price targets unchanged.
The Economic Times
Like
Reply
V
Reputation: 0 • Aug 31 4:20 AM

Type
Buy
Instrument
JMFINANCIL
Entry Price
₹92.5
Price@Trade
₹92.7
Target Price
₹110
Stop Price
₹80
Valid Till
Aug 31, 2022 3:20 AM
Margin
₹9,250 approx for 100 Qty
Status
Exited
Exit Price
₹92.7
Net P&L
+₹20 (+0.22%)
Like
Reply (2)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Aug 31 4:56 AM

Update
Trade Entered
Entry Price
₹92.5
Venu K @VENU2021
Sep 1 4:53 AM

Update
Exited
Exit Price
₹92.7
Net P&L
+₹20 (+0.22%)

Type
Buy
Instrument
JMFINANCIL
Entry Price
₹90.75
Price@Trade
₹90.75
Target Price
₹130
Stop Price
₹75
Valid Till
Aug 24, 2022 3:20 AM
Margin
₹453,750 approx for 5000 Qty
Status
Exited
Exit Price
₹92.45
Net P&L
+₹8,500 (+1.87%)
Like
Reply (1)
swap_vert
Trade
See all replies
Manusharma02 @manusharma02
Aug 26 2:55 AM

Update
Exited
Exit Price
₹92.45
Net P&L
+₹8,500 (+1.87%)

Type
Buy
Instrument
JMFINANCIL
Entry Price
₹90.95
Price@Trade
₹90.95
Target Price
₹130
Stop Price
₹75
Valid Till
Aug 24, 2022 3:20 AM
Margin
₹45,475 approx for 500 Qty
Status
Exited
Exit Price
₹90.6
Net P&L
-₹175 (-0.38%)
Like
Reply (1)
swap_vert
Trade
See all replies
Manusharma02 @manusharma02
Aug 24 6:10 AM

Update
Exited
Exit Price
₹90.6
Net P&L
-₹175 (-0.38%)
S
Reputation: 0 • Aug 20 5:16 AM

Type
Buy
Instrument
JMFINANCIL
Entry Price
₹90.25
Price@Trade
₹90.2
Target Price
₹130
Stop Price
₹80
Valid Till
Aug 19, 2022 3:20 AM
Margin
₹67,687.5 approx for 750 Qty
Status
Active
Swing
Like
Reply (1)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Aug 20 5:17 AM

Update
Trade Entered
Entry Price
₹90.25
N
Reputation: 17,842 • Aug 20 12:11 PM
Emcure Pharma files DRHP for IPO
Pune-based Emcure Pharmaceuticals, one of Indias biggest unlisted pharma companies, filed its draft red herring prospectus (DRHP) with the market regulator Sebi on Thursday to raise money through an initial public offer.
The Economic Times
Like
Reply
N
Reputation: 17,842 • Aug 19 9:31 AM
Emcure Pharma files draft paper for Rs 5,000 cr IPO
Emcure claims to be an R&D driven company with a differentiated product portfolio that includes orals, injectables and biologics, as well as an mRNA platform through which it is currently developing a COVID-19 vaccine, which has enabled it to reach a range of target markets across over 70 countries with a strong presence in Europe and Canada.
The Economic Times
Like
Reply

JMFINANCIL Ratings

Long term JMFINANCIL rating by FrontPage users
0/5 (0 Ratings)0
Find answers to all your questions on live JMFINANCIL message board: Is JMFINANCIL buy or sell? Should I buy JMFINANCIL shares? Why are JMFINANCIL shares falling? Should I invest in JMFINANCIL stock?

Join FrontPage
Hero Img
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • JMFINANCIL - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization7,890.86
    Enterprise Value7,876.57
    Price to Earnings79.32
    Price to Book Value3.18
    Return on Capital Employed0.08
    Return on Equity0.06
    Face Value1
    Dividend Yield0.01
  • JMFINANCIL - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    26-Jul-18AnandRathiBuy136
    23-Aug-17Antique Stock BrokingBuy171
    JMFINANCIL Brokerage Price Target
  • JMFINANCIL Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Sep 2792.894.2592.4593
    Sep 249293.19092.3
    Sep 2390.992.289.6591.5
    Sep 2290.291.589.6590.05
    Sep 2189.8590.788.589.8
  • JMFINANCIL Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹90.71
    30 Day Moving Average₹91.05
    50 Day Moving Average₹95.81
    100 Day Moving Average₹92.42
    200 Day Moving Average₹89.81
  • JMFINANCIL - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue243161.920.5
    Operating Profit184146.170.26
    Profit Before Tax149106.930.39
    Net Income136106.730.27
  • JMFINANCIL - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds2,4822,3770.04
    Total Liabilities170179-0.05
    Total Assets2,6522,5580.04
  • JMFINANCIL - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity185257.17-0.28
    Cash from Investing Activity-440101.31-5.34
    Cash from Financing Activity281-359.84-1.78
    Net Cash Flow26-1.36-20.12
  • JMFINANCIL - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.050.05
    Return on Equity0.060.06
    Return on Capital Employed0.080.08
  • JMFINANCIL - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue1.34
    3 Year CAGR Growth in Operating Profit1.09
    3 Year CAGR Growth in EBIDTA1.08
    3 Year CAGR Growth in Net Income0.74
    3 Yr CAGR Growth - Diluted EPS0.62
  • JMFINANCIL - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue3.35
    5 Year CAGR Growth in Operating Profit2.78
    5 Year CAGR Growth in EBIDTA2.75
    5 Year CAGR Growth in Net Income2.04
    3 Yr CAGR Growth - Diluted EPS1.7
  • JMFINANCIL - Recent News

    keyboard_arrow_down
    NewsBot
    Just now
    Buy JM Financial, target price Rs 99: HDFC Securities
    The Economic Times
    NewsBot
    Sep 16 5:26 AM
    JM Financial's subsidiary to raise up to Rs 500 crore
    The Economic Times
    NewsBot
    Sep 16 3:31 AM
    Buy JM Financial, target price Rs 96: HDFC Securities
    The Economic Times
    NewsBot
    Aug 31 6:56 AM
    Will Burger King India's entry into 4th most populated country make it a tastier bet?
    The Economic Times
    NewsBot
    Aug 20 12:11 PM
    Emcure Pharma files DRHP for IPO
    The Economic Times
    NewsBot
    Aug 19 9:31 AM
    Emcure Pharma files draft paper for Rs 5,000 cr IPO
    The Economic Times
    NewsBot
    Aug 19 6:46 AM
    Emcure Pharma files draft paper for Rs 4,000 cr IPO
    The Economic Times
    NewsBot
    Aug 17 4:36 AM
    IDBI Trusteeship approaches NCLT against Noida developer Shipra Estate
    The Economic Times
    NewsBot
    Aug 13 3:21 AM
    Govt-backed IFCI slips to high-yield grade, raises investor concern
    The Economic Times
    NewsBot
    Aug 12 12:11 PM
    Aditya Birla AMC likely to launch IPO in September
    The Economic Times
  • JMFINANCIL - Related Communities

    keyboard_arrow_down
    Bajaj Finance Ltd. NSE: BAJFINANCE | ...
    Indiabulls Housing Finance Ltd. NSE: ...
    Housing Development Finance Corporati...
    Bajaj Finserv Ltd. NSE: BAJAJFINSV | ...
    HDFC Life Insurance Company Ltd. NSE:...
    LIC Housing Finance Ltd. NSE: LICHSGF...
    L&T Finance Holdings Ltd. NSE: L&TFH ...
    Equitas Holdings Ltd. NSE: EQUITAS | ...
    Dewan Housing Finance Corporation Ltd...
    Mahindra & Mahindra Financial Service...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.